We are live on ! Find out more
BCHI

GMO Beyond China ETF

5 hedge funds and large institutions have $3.35M invested in GMO Beyond China ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

43.05% more ownership

Funds ownership: 0%43.05% (+43%)

Holders
5
Holders Change
+5
Holders Change %
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
1
Cresset Asset Management
Illinois
$2.14M +$2.18M +88,200 New
HC
2
Hara Capital
Washington
$491K +$499K +20,212 New
Citadel Advisors
3
Citadel Advisors
Florida
$412K +$418K +16,940 New
Jane Street
4
Jane Street
New York
$301K +$306K +12,375 New
UBS Group
5
UBS Group
Switzerland
$583 +$593 +24 New

BCHI Hedge Fund Activity: Q1 2025 in Review

5 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in GMO Beyond China ETF (BCHI) for Q1 2025, worth a combined $3.35M.

Buyers outnumbered sellers: 5 funds opened new BCHI positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cresset Asset Management, opening a new position worth an estimated $2.18M.

  • 5 institutional investors held GMO Beyond China ETF (BCHI) as of Q1 2025, up from 0 in Q4 2024.
  • Funds reported $3.35M of GMO Beyond China ETF stock for Q1 2025.
  • 5 funds opened new GMO Beyond China ETF positions in Q1 2025 and 0 closed out, a net change of +5 holders.
  • The largest GMO Beyond China ETF buyer in Q1 2025 was Cresset Asset Management, an estimated $2.18M added.

Based on aggregated 13F filings for Q1 2025.